Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah

Chris Stockmann1, Krow Ampofo, Carrie L Byington

  • 1Division of Pediatric Infectious Diseases, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA. chris.stockmann@hsc.utah.edu

Pediatrics
|August 28, 2013
PubMed

Insights

Pediatric pneumococcal meningitis remains a significant threat, with similar death and disability rates from both vaccine and non-vaccine serotypes. Continued immunization and surveillance are crucial.

Area of Science:

  • Pediatric infectious diseases
  • Vaccinology
  • Epidemiology

Background:

  • The 7-valent pneumococcal conjugate vaccine (PCV7) significantly reduced pediatric pneumococcal meningitis incidence in the US.
  • However, cases persist, raising questions about the comparative impact of PCV7 versus non-PCV7 serotypes on disease severity.

Purpose of the Study:

  • To compare the morbidity and mortality associated with pneumococcal meningitis caused by PCV7 and non-PCV7 serotypes in children.
  • To assess the long-term neurologic sequelae in survivors.

Main Methods:

  • A retrospective cohort study of laboratory-confirmed pneumococcal meningitis cases in Utah children (1997-2010).
  • Review of medical records for clinical data and follow-up on neurologic sequelae.

Main Results:

  • PCV7 serotypes decreased from 64% to 25% post-vaccine licensure (P < .01).
  • Overall case fatality rate was 13%, with no significant difference between PCV7 and non-PCV7 serotypes (P = .7).
  • Children with PCV7 serotype meningitis were more likely to require mechanical ventilation (68% vs 34%; P < .01), and 63% of survivors had neurologic sequelae, similar for both serotype groups (P = .1).

Conclusions:

  • Pneumococcal meningitis continues to cause high mortality and morbidity, regardless of serotype.
  • Neurologic sequelae are common in survivors of both PCV7 and non-PCV7 serotype meningitis.
  • The ongoing disease burden highlights the need for enhanced immunization strategies and surveillance, especially with the advent of PCV13.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.